National Vision Holdings, Inc. splits its revenue into 8 lines in its filings. The largest line in fiscal 2025, which ended Jan 3, 2026 was Eyeglasses And Sunglasses at $1.3 billion, 64% of the total.
USD in millions. The percent under a figure is the change from the year before.
| Line |
FY 2026
Jul 4, 2026
|
FY 2025
Jan 3, 2026
|
FY 2024
Dec 28, 2024
|
FY 2023
Dec 30, 2023
|
FY 2022
Dec 31, 2022
|
FY 2021
Jan 1, 2022
|
FY 2020
Jan 2, 2021
|
FY 2019
Dec 28, 2019
|
FY 2018
Dec 29, 2018
|
FY 2017
Dec 30, 2017
|
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
2,033
|
1,987
|
1,823
|
1,756
|
1,645
|
2,080
|
1,712
|
1,724
|
1,537
|
1,375
|
| Eyeglasses And Sunglasses |
—
|
1,269
+10.8%
share 63.9%
|
1,146
+2.8%
share 62.8%
|
1,115
+6.6%
share 63.5%
|
1,046
-12.9%
share 63.6%
|
1,201
+27.0%
share 57.8%
|
946
-0.2%
share 55.3%
|
948
+11.3%
share 55.0%
|
851
+11.5%
share 55.4%
|
763
share 55.5%
|
| Services And Plans |
—
|
—
|
—
|
—
|
—
|
361
+23.1%
share 17.4%
|
293
-1.6%
share 17.1%
|
298
+11.6%
share 17.3%
|
267
+8.6%
share 17.4%
|
246
share 17.9%
|
| Contact Lenses |
—
|
324
share 16.3%
|
—
|
301
+4.4%
share 17.2%
|
289
-43.4%
share 17.6%
|
510
+9.4%
share 24.5%
|
466
-1.0%
share 27.2%
|
471
+14.7%
share 27.3%
|
411
+14.5%
share 26.7%
|
359
share 26.1%
|
| Exam |
—
|
255
+9.0%
share 12.8%
|
234
+12.4%
share 12.8%
|
208
+17.1%
share 11.8%
|
177
share 10.8%
|
—
|
—
|
—
|
—
|
—
|
| Product Protection Plans |
—
|
74
+1.0%
share 3.7%
|
73
+1.1%
share 4.0%
|
72
-4.1%
share 4.1%
|
75
share 4.6%
|
—
|
—
|
—
|
—
|
—
|
| Eyecare Clubs |
—
|
55
+1.7%
share 2.7%
|
54
+0.9%
share 2.9%
|
53
+2.8%
share 3.0%
|
52
share 3.1%
|
—
|
—
|
—
|
—
|
—
|
| Management Of Operations |
—
|
—
|
—
|
—
|
35
-16.8%
share 2.1%
|
42
+24.9%
share 2.0%
|
33
-5.9%
share 2.0%
|
36
+2.3%
share 2.1%
|
35
-5.4%
share 2.3%
|
37
share 2.7%
|
| Accessories And Other |
—
|
11
+11.6%
share 0.6%
|
10
+45.1%
share 0.6%
|
7
+28.0%
share 0.4%
|
5
-21.9%
share 0.3%
|
7
+16.2%
share 0.3%
|
6
-18.6%
share 0.4%
|
7
-1.1%
share 0.4%
|
7
+2.9%
share 0.5%
|
7
share 0.5%
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Ophthalmic Goods (SIC 3851)
- Listed as
- EYE (Nasdaq)
- Fiscal year ends
- January 2
- Incorporated in
- DE
- Headquarters
- Alpharetta, GA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1710155
Other Ophthalmic Goods companies
- Alcon Inc ALC
- Cooper Companies, Inc. COO
- Bausch & Lomb Corp BLCO
- Warby Parker Inc. WRBY
- Staar Surgical Co STAA
- RxSight, Inc. RXST
- Innovative Eyewear Inc LUCY
Source: SEC EDGAR filings. This is company-reported data, not investment advice.